BRIEF published on 08/01/2024 at 11:35, 2 years 1 month ago Iute Group Announces Unaudited 6M 2024 Results and Upcoming Earnings Call Financial Services Earnings Call Unaudited Results Iute Group 2024 Earnings
BRIEF published on 08/01/2024 at 11:35, 2 years 1 month ago Iute Group annonce ses résultats non audités pour le 6M 2024 et son prochain appel à résultats Appel Aux Résultats Services Financiers Groupe Iute Gains 2024 Résultats Non Audités
BRIEF published on 08/01/2024 at 11:35, 2 years 1 month ago Renewi PLC Announces Major Holdings Change Voting Rights Major Holdings Renewi Plc Financial Notification Avenue Europe
BRIEF published on 08/01/2024 at 11:35, 2 years 1 month ago Renewi PLC annonce un changement majeur dans ses participations Renewi Plc Droit De Vote Notification Financière Principaux Titres Avenue Europe
BRIEF published on 08/01/2024 at 11:25, 2 years 1 month ago MindBio Therapeutics Appoints Haywood Securities for Strategic Investment Advisory Psychedelic Medicine Strategic Investment Clinical Trials Mental Health Biopharmaceutical
BRIEF published on 08/01/2024 at 11:25, 2 years 1 month ago MindBio Therapeutics nomme Haywood Securities pour un conseil en investissement stratégique Investissement Stratégique Biopharmaceutique Santé Mentale Essais Cliniques Médecine Psychédélique
BRIEF published on 08/01/2024 at 11:09, 2 years 1 month ago PRIMEPULSE Acquires Majority Stake in AI-Enabled IT Service Provider Samhammer AG Technology Investment PRIMEPULSE Samhammer AG AI-based Services
BRIEF published on 08/01/2024 at 11:09, 2 years 1 month ago PRIMEPULSE acquiert une participation majoritaire dans le fournisseur de services informatiques basés sur l'IA Samhammer AG Technologie Investissement Services Basés Sur L'IA PRIMEPULSE Samhammer AG
BRIEF published on 08/01/2024 at 10:05, 2 years 1 month ago ISG Provider Lens™ Upgrades GFT's AI Ranking in Google Cloud Data Analytics Google Cloud GFT Technologies ISG Provider Lens AI Ranking
BRIEF published on 08/01/2024 at 10:05, 2 years 1 month ago ISG Provider Lens™ améliore le classement IA de GFT dans Google Cloud Google Cloud Analyse Des Données Technologies GFT Objectif Du Fournisseur ISG Classement IA
Published on 09/11/2026 at 17:00, 4 hours 19 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 4 hours 19 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 5 hours 54 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 6 hours 19 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 6 hours 49 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 19:44, 1 hour 34 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 3 hours 3 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 3 hours 19 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 14 hours 19 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 14 hours 19 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 14 hours 19 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 14 hours 19 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
